Isotonitazene has been identified in eight blood specimens associated with postmortem death investigations in the United States since August 2019. Isotonitazene was first reported in August 2019 based on the results from seized drug and toxicology casework in Europe (Belgium) and Canada (Alberta); the Canadian toxicology case was collected in March 2019.
(Publisher abstract provided.)
Similar Publications
- Cognitive and contextual influences in determination of latent fingerprint suitability for identification judgments
- Introducing the United States Extremis Crime Database (ECDB)
- Toward a Developmental Model of Continuity and Change in PTSD Symptoms following Exposure to Traumatic and Adverse Experiences